Survey for patients with esophageal cancer and upper digestive diseases
Official title: Mayo Clinic Upper Digestive Disease Survey
Run by Mayo Clinic · NCT02530983 · Data updated 2026-11-12
This study is trying to gather information from patients with esophageal cancer and other upper digestive issues to see how they are doing after treatment and improve future care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | August 15, 2015 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | March 30, 2026 |
| Trial ID | NCT02530983 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients who are undergoing or have already undergone an esophagectomy or esophageal reconstruction.
✕Probably not a fit
Patients who do not have esophageal cancer or upper digestive diseases may not receive any benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study utilizes the Mayo Clinic Upper Digestive Disease Survey to evaluate patients undergoing esophageal reconstruction or treatment for upper digestive diseases. It aims to standardize and validate outcome measures through a series of questionnaires that assess various aspects of patient health and recovery. Participants will complete the survey at specified intervals post-surgery or diagnosis, allowing for the collection of comprehensive data on demographics, clinical outcomes, and symptom management. The findings will contribute to the development of treatment algorithms and enhance pre-operative education for patients.
Why it matters
Potential benefit: If successful, this study could lead to improved management and outcomes for patients with esophageal cancer and upper digestive diseases.
How similar studies have gone: Other studies utilizing standardized questionnaires for patient outcomes in similar conditions have shown promise, indicating that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients undergoing or having already undergone an esophagectomy or esophageal reconstruction.
Where it's running
-
Mayo Clinic
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Luis Tapias Vargas, MD — Mayo Clinic
- Study coordinator: Mohamad Khair Abou Chaar, MD
- Email: AbouChaar.MohamadKhairM@mayo.edu
- Phone: 507-422-9936
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Paravertebral Catheter Analgesia Versus Epidural Analgesia for Totally Minimally Invasive Esophagectomy
This trial tests whether paravertebral catheter analgesia can provide comparable pain control to epidural analgesia for patients undergoing totally minimally invasive esophagectomy.
-
Combination treatment for advanced esophageal cancer
This study is testing a new combination of treatments for patients with advanced esophageal cancer to see if it is safe and effective for those who haven't had treatment before.
-
Combination therapies for advanced gastroesophageal cancer
This study is testing two different treatment combinations for people with advanced stomach cancer to see which one works better after their first treatment didn't help.
-
Review of esophageal cancer outcomes at Memorial Sloan Kettering Cancer Center
This study looks at how the edges of removed tumors affect survival in patients with advanced esophageal cancer after surgery.
-
Rehabilitation and recovery program for esophageal and gastric cancer patients
This study is testing a personalized rehabilitation program for people with esophageal and gastric cancer to see if it can improve their quality of life and help manage their symptoms.
-
CA-4948 combined with chemotherapy and immunotherapy for advanced gastric and esophageal cancer
This study is testing a new treatment combining CA-4948 with chemotherapy and immunotherapy to see if it helps people with advanced stomach and esophageal cancer who haven't had other treatments yet.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.